Nurix Therapeutics is expected to announce quarterly earnings below estimates, but potential outperformance indicated

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is set to announce its quarterly earnings with an estimated EPS of -$0.72 and revenue of $16.3 million. Analysts predict a potential outperformance with a projected EPS of -$0.70 due to higher revenue expectations. Financial ratios reflect investor confidence, despite challenges like a negative earnings yield of -19.59%.